Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Berg, Forma/Celgene, Intarcia, & More 04/04/14 Boston
AvidBiotics Taps Nature for Two Ways To Fight Lethal Microbes 04/03/14 San Francisco
What’s Hot in Boston Biotech: Here’s the Agenda for April 16 03/27/14 Boston
The Big Guys Have Lost Their Iron Grip, and It’s All Good 01/20/14 National
East Coast Biotech Roundup: JP Morgan Edition 01/17/14 Boston
East Coast Biotech Roundup: Curoverse, Sia, Trinity, & (Much) More 12/20/13 Boston
Cubist Shares Climb As Antibiotic Scores in Phase 3 Again 12/16/13 Boston
Building Biotechs to Last: The Photos 12/12/13 San Francisco
Layoffs Hit Optimer Following Cubist Buyout 12/06/13 New York
East Coast Biotech Roundup: Juno, Editas, Celgene, & More 12/06/13 Boston
Cubist’s Calixa Buyout Bears Fruit as Antibiotic Hits First Phase 3 Mark 11/25/13 Boston
Flagship Takes a Stab at Microbiome Therapy With Seres Health 11/21/13 Boston
East Coast Biotech Roundup: Pronutria, Alzheon, Nextcode, & More 10/25/13 Boston
9 Takeaways from Boston’s Life Science Disruptors 10/04/13 Boston
East Coast Life Sciences Roundup: Aileron, Enzymatics, Acton, & More 09/06/13 Boston
East Coast Biotech Roundup: Cubist, Acetylon, Foundation, & More 08/02/13 Boston
Cubist Adds Antibiotic Punch, Buys Trius and Optimer for $1.24B 07/30/13 Boston
San Diego Life Sciences Roundup: Optimer, Ambit, AnaptysBio, & More 05/17/13 San Diego
East Coast Life Sciences Roundup: Optimer, Bind, Pfizer, and More 04/05/13 Boston
San Diego Life Sciences Roundup: Qualcomm, Amylin, Organovo & More 04/04/13 San Diego
Optimer Shares Soar Amid Reports of Buyout Interest 04/02/13 San Diego
Biotech VCs Aren’t Lemmings Anymore. They’re Lone Rangers 03/25/13 National
East Coast Life Sciences Roundup: Third Rock, SciFluor, Cubist 03/01/13 Boston
Cubist Grabs Option to Acquire Adynxx, Getting Drug for Pain 02/25/13 Boston
East Coast Life Sciences Roundup: Ariad, Pfizer, Cubist, More 01/25/13 Boston
LinkedIn: The Quiet Force Transforming Biotech & Pharma 11/05/12 National
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
Kala, ImmunoGen, Boring Biotech, & More Boston Life Sciences News 07/13/12 Boston
The Best Boring Companies in Biotech 07/09/12 National
Kineta, Playing for Bunt Singles, Builds a Biotech Company Without VC Bucks 06/06/12 Seattle
Page 1 of 4 next page »